{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T05:38:35Z","timestamp":1775281115944,"version":"3.50.1"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T00:00:00Z","timestamp":1539129600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Urol Rep"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s11934-018-0847-3","type":"journal-article","created":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T06:43:21Z","timestamp":1539153801000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Management of Overactive Bladder Symptoms After Radical Prostatectomy"],"prefix":"10.1007","volume":"19","author":[{"given":"Benoit","family":"Peyronnet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin M.","family":"Brucker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,10]]},"reference":[{"key":"847_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.20138","volume":"62","author":"R Siegel","year":"2012","unstructured":"Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10\u201329.","journal-title":"CA Cancer J Clin"},{"key":"847_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ejca.2016.07.021","volume":"67","author":"A Trama","year":"2016","unstructured":"Trama A, Botta L, Nicolai N, Rossi PG, Contiero P, Fusco M, et al. Prostate cancer changes in clinical presentation and treatments in two decades: an Italian population-based study. Eur J Cancer. 2016;67:91\u20138.","journal-title":"Eur J Cancer"},{"issue":"7","key":"847_CR3","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/pros.23496","volume":"78","author":"J Chen","year":"2018","unstructured":"Chen J, Oromendia C, Halpern JA, Ballman KV. National trends in management of localized prostate cancer : a population based analysis 2004-2013. Prostate. 2018;78(7):512\u201320.","journal-title":"Prostate"},{"issue":"2","key":"847_CR4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.5534\/wjmh.2016.34.2.73","volume":"34","author":"P Capogrosso","year":"2016","unstructured":"Capogrosso P, Salonia A, Briganti A, Montorsi F. Postprostatectomy erectile dysfunction: a review. World J Mens Health. 2016;34(2):73\u201388.","journal-title":"World J Mens Health"},{"issue":"4","key":"847_CR5","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.sxmr.2017.05.001","volume":"5","author":"V Trofimenko","year":"2017","unstructured":"Trofimenko V, Myers JB, Brant WO. Post-prostatectomy incontinence: how common and bothersome is it really? Sex Med Rev. 2017;5(4):536\u201343.","journal-title":"Sex Med Rev"},{"issue":"6","key":"847_CR6","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.eururo.2016.09.031","volume":"71","author":"J Heesakkers","year":"2017","unstructured":"Heesakkers J, Farag F, Bauer RM, Sandhu J, De Ridder D, Stenzl A. Pathophysiology and contributing factors in postprostatectomy incontinence: a review. Eur Urol. 2017;71(6):936\u201344.","journal-title":"Eur Urol"},{"issue":"6","key":"847_CR7","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1002\/nau.23556","volume":"37","author":"Yoshihisa Matsukawa","year":"2018","unstructured":"\u2022 Matsukawa Y, Yoshino Y, Ishida S, et al. De novo overactive bladder after robot-assisted laparoscopic radical prostatectomy. Neurourol Urodyn. 2018. https:\/\/doi.org\/10.1002\/nau.23556 Prospective series identifying low preoperative maximum urethral closure pressure (MUCP) and greater decrease in MUCP postoperatively as significant predictors of urgency after radical prostatectomy strengthening the idea of an urethrogenic mechanism in the pathophysiology of post-prostatectomy OAB.","journal-title":"Neurourology and Urodynamics"},{"key":"847_CR8","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.urology.2016.05.007","volume":"94","author":"GW Hosier","year":"2016","unstructured":"\u2022 Hosier GW, Tennankore KK, Himmelman JG, Gajewski J, Cox AR. Overactive bladder and Storage Lower Urinary Tract Symptoms Following Radical Prostatectomy. Urology. 2016;94:193\u20137 Retrospective series highlighting adjuvant or salvage radiotherapy as a major risk factor of post-prostatectomy OAB.","journal-title":"Urology"},{"key":"847_CR9","doi-asserted-by":"crossref","unstructured":"Aning JJ, MacKenzie KR, Fabricius M, et al. Detailed analysis of patient-reported lower urinary tract symptoms and effect on quality of life after robotic radical prostatectomy. Urol Oncol. 2018; in press.","DOI":"10.1016\/j.urolonc.2018.05.017"},{"issue":"12","key":"847_CR10","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1111\/j.1464-410X.2011.10623.x","volume":"109","author":"M Boettcher","year":"2012","unstructured":"Boettcher M, Haselhuhn A, Jakse G, Brehmer B, Kirschner-Hermanns R. Overactive bladder syndrome: an underestimated long-term problem after treatment of patients with localized prostate cancer? BJU Int. 2012;109(12):1824\u201330.","journal-title":"BJU Int"},{"issue":"6","key":"847_CR11","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1016\/j.juro.2007.08.004","volume":"178","author":"D Slova","year":"2007","unstructured":"Slova D, Lepor H. The short-term and long-term effects of radical prostatectomy on lower urinary tract symptoms. J Urol. 2007;178(6):2397\u2013400.","journal-title":"J Urol"},{"issue":"6","key":"847_CR12","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/S0090-4295(02)01989-1","volume":"60","author":"M Sebesta","year":"2002","unstructured":"Sebesta M, Cespedes RD, Luhman E, Optenberg S, Thompson IM. Questionnaire-based outcomes of urinary incontinence and satisfaction rates after radical prostatectomy in a national study population. Urology. 2002;60(6):1055\u20138.","journal-title":"Urology"},{"issue":"5","key":"847_CR13","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/j.1464-410X.2009.09189.x","volume":"106","author":"C Song","year":"2010","unstructured":"Song C, Lee J, Hong JH, Choo MS, Kim CS, Ahn H. Urodynamic interpretation of changing bladder function and voiding pattern after radical prostatectomy: a long-term follow-up. BJU Int. 2010;106(5):681\u20136.","journal-title":"BJU Int"},{"issue":"3","key":"847_CR14","first-page":"234","volume":"69","author":"AL Pastore","year":"2017","unstructured":"\u2022 Pastore AL, Palleschi G, Illiano E, Zucchi A, Carbone A, Costantini E. The role of detrusor overactivity in urinary incontinence after radical prostatectomy: a systematic review. Minerva Urol Nefrol. 2017;69(3):234\u201341 Systematic review reporting a prevalence of detrusor overactivity (DO) after radical prostatectomy ranging from 3 to 63% and identifying preoperative DO as the main risk factor of postoperative DO.","journal-title":"Minerva Urol Nefrol"},{"issue":"Suppl 3","key":"847_CR15","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1002\/nau.22635","volume":"33","author":"C Chapple","year":"2014","unstructured":"Chapple C. Chapter 2: pathophysiology of neurogenic detrusor overactivity and the symptom complex of \u201coveractive bladder\u201d. Neurourol Urodyn. 2014;33(Suppl 3):S6\u201313.","journal-title":"Neurourol Urodyn"},{"issue":"5","key":"847_CR16","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1002\/nau.22582","volume":"33","author":"AT Hanna-Mitchell","year":"2014","unstructured":"Hanna-Mitchell AT, Kashyap M, Chan WV, Andersson KE, Tannenbaum C. Pathophysiology of idiopathic overactive bladder and the success of treatment: a systematic review from ICI-RS 2013. Neurourol Urodyn. 2014;33(5):611\u20137.","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"847_CR17","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0022-5347(05)00067-4","volume":"175","author":"H Hashim","year":"2006","unstructured":"Hashim H, Abrams P. Is the bladder a reliable witness for predicting detrusor overactivity? J Urol. 2006;175(1):191\u20134.","journal-title":"J Urol"},{"issue":"1","key":"847_CR18","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.eururo.2007.03.051","volume":"52","author":"M Porena","year":"2007","unstructured":"Porena M, Mearini E, Mearini L, Vianello A, Giannantoni A. Voiding dysfunction after radical retropubic prostatectomy: more than external urethral sphincter deficiency. Eur Urol. 2007;52(1):38\u201345.","journal-title":"Eur Urol"},{"issue":"4","key":"847_CR19","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/S0022-5347(01)62525-4","volume":"160","author":"MA Ficazzola","year":"1998","unstructured":"Ficazzola MA, Nitti VW. The etiology of post-radical prostatectomy incontinence and correlation of symptoms with urodynamic findings. J Urol. 1998;160(4):1317\u201320.","journal-title":"J Urol"},{"key":"847_CR20","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1093\/brain\/54.2.177","volume":"54","author":"FJF Barrington","year":"1931","unstructured":"Barrington FJF. The component reflexes of micturition in the cats, parts 1 and 2. Brain. 1931;54:177\u201388.","journal-title":"Brain"},{"issue":"1","key":"847_CR21","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1097\/00005392-199907000-00069","volume":"162","author":"SY Jung","year":"1999","unstructured":"Jung SY, Fraser MO, Ozawa H, et al. Urethral afferent nerve activity affects the micturition reflex; implication for the relationship between stress incontinence and detrusor instability. J Urol. 1999;162(1):204\u201312.","journal-title":"J Urol"},{"key":"847_CR22","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00345-003-0340-5","volume":"21","author":"A Shafik","year":"2003","unstructured":"Shafik A, Shafik AA, El-Sibai O, et al. Role of positive urethrovesical feedback in vesical evacuation. The concept of a second micturition reflex: the urethrovesical reflex. World J Urol. 2003;21:167\u201370.","journal-title":"World J Urol"},{"issue":"3","key":"847_CR23","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1097\/01.ju.0000046384.71563.51","volume":"169","author":"A Shafik","year":"2003","unstructured":"Shafik A, el-Sibai O, Ahmed I. Effect of urethral dilation on vesical motor activity: identification of the urethrovesical reflex and its role in voiding. J Urol. 2003;169(3):1017\u20139.","journal-title":"J Urol"},{"issue":"8","key":"847_CR24","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.purol.2012.04.011","volume":"22","author":"K Hubeaux","year":"2012","unstructured":"Hubeaux K, Deffieux X, Desseaux K, Verollet D, Damphousse M, Amarenco G. Stand up urgency: is this symptom related to a urethral mechanism? Prog Urol. 2012;22(8):475\u201381.","journal-title":"Prog Urol"},{"issue":"3","key":"847_CR25","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/S0022-5347(05)67827-5","volume":"163","author":"SR Serels","year":"2000","unstructured":"Serels SR, Rackley RR, Appell RA. Surgical treatment for stress urinary incontinence associated with valsalva induced detrusor instability. J Urol. 2000;163(3):884\u20137.","journal-title":"J Urol"},{"issue":"3","key":"847_CR26","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.urology.2014.04.044","volume":"84","author":"N Haga","year":"2014","unstructured":"\u2022\u2022 Haga N, Ogawa S, Yabe M, et al. Association between postoperative pelvic anatomic features on magnetic resonance imaging and lower tract urinary symptoms after radical prostatectomy. Urology. 2014;84(3):642\u20139 Series reporting an association between presence of urine in proximal urethra at rest on postoperative MRI and urgency after radical prostatectomy strengthening the idea of an urethrogenic mechanism in the pathophysiology of post-prostatectomy OAB.","journal-title":"Urology"},{"issue":"5","key":"847_CR27","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1002\/nau.23495","volume":"37","author":"Jo\u00e3o F. Neves Neto","year":"2018","unstructured":"Neves Neto JF, Palomino Z, Mizuno Watanabe IK, et al. Pretransplant defunctionalized bladder-overrated condition? Neurourol Urodyn. 2018;in press. https:\/\/doi.org\/10.1002\/nau.23495 .","journal-title":"Neurourology and Urodynamics"},{"issue":"3","key":"847_CR28","first-page":"5695","volume":"18","author":"TA Afraa","year":"2011","unstructured":"\u2022 Afraa TA, Campeau L, Mahfouz W, Corcos J. Urodynamic parameters evolution after artificial urinary sphincter implantation for post-radical prostatectomy incontinence with concomitant bladder dysfunction. Can J Urol. 2011;18(3):5695\u20138 Retrospective series showing complete resolution of detrusor overactivity and impaired bladder compliance after artificial urinary sphincter implantation in a vast majority of patients with post-prostatectomy incontinence suggesting artifactual defunctionalized bladder as an explanation of these urodynamic findings.","journal-title":"Can J Urol"},{"issue":"2","key":"847_CR29","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/nau.10052","volume":"21","author":"P Abrams","year":"2002","unstructured":"Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21(2):167\u201378.","journal-title":"Neurourol Urodyn"},{"key":"847_CR30","doi-asserted-by":"publisher","first-page":"E33","DOI":"10.5489\/cuaj.192","volume":"7","author":"DE Chung","year":"2013","unstructured":"\u2022 Chung DE, Dillon B, Kurta J, et al. Detrusor underactivity is prevalent after radical prostatectomy: a urodynamic study including risk factors. Can Urol Assoc J. 2013;7:E33\u20137 Retrospective series reporting 41% of detrusor underactivity after radical prostatectomy.","journal-title":"Can Urol Assoc J"},{"issue":"3","key":"847_CR31","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.eururo.2017.03.045","volume":"72","author":"AD Uren","year":"2017","unstructured":"Uren AD, Cotterill N, Harding C, Hillary C, Chapple C, Klaver M, et al. Qualitative Exploration of the Patient Experience of Underactive Bladder. Eur Urol. 2017;72(3):402\u20137.","journal-title":"Eur Urol"},{"key":"847_CR32","doi-asserted-by":"crossref","unstructured":"Kim DK. Origin of urgency symptom in underactive bladder: commentary on \u201cUnderactive Bladder: Clinical Features, Urodynamic Parameters, and Treatment\u201d. 2015;Int Neurourol J, 19(4):293\u20134.","DOI":"10.5213\/inj.2015.19.4.293"},{"issue":"5","key":"847_CR33","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/j.juro.2015.11.072","volume":"195","author":"D Liberman","year":"2016","unstructured":"Liberman D, Jarosek S, Virnig BA, Chu H, Elliott SP. The Patient Burden of Bladder Outlet Obstruction after Prostate Cancer Treatment. J Urol. 2016;195(5):1459\u201363.","journal-title":"J Urol"},{"issue":"2","key":"847_CR34","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.eururo.2014.08.061","volume":"67","author":"SL Jarosek","year":"2015","unstructured":"\u2022 Jarosek SL, Virnig BA, Chu H, Elliott SP. Propensity-weighted long-term risk of urinary adverse events after prostate cancer surgery, radiation, or both. Eur Urol. 2015;67(2):273\u201380 Population-based study showing a cumulative prevalence of 20.3% of urethral stricture 10\u00a0years after radical prostatectomy.","journal-title":"Eur Urol"},{"issue":"1","key":"847_CR35","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/bju.13598","volume":"119","author":"MJ Drake","year":"2017","unstructured":"Drake MJ, Kanai A, Bijos DA, Ikeda Y, Zabbarova I, Vahabi B, et al. The potential role of unregulated autonomous bladder micromotions in urinary storage and voiding dysfunction; overactive bladder and detrusor underactivity. BJU Int. 2017;119(1):22\u20139.","journal-title":"BJU Int"},{"issue":"2","key":"847_CR36","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/pcan.2017.1","volume":"20","author":"M Gacci","year":"2017","unstructured":"Gacci M, Russo GI, De Nunzio C, et al. Meta-analysis of metabolic syndrome and prostate cancer. Prostate Cancer Prostatic Dis. 2017;20(2):146\u201355.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"9","key":"847_CR37","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11934-016-0620-4","volume":"17","author":"M Gacci","year":"2016","unstructured":"Gacci M, Sebastianelli A, Salvi M, de Nunzio C, Tubaro A, Gravas S, et al. The impact of central obesity on storage luts and urinary incontinence after prostatic surgery. Curr Urol Rep. 2016;17(9):61.","journal-title":"Curr Urol Rep"},{"issue":"5","key":"847_CR38","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1056\/NEJMoa0806375","volume":"360","author":"LL Subak","year":"2009","unstructured":"Subak LL, Wing R, West DS, Franklin F, Vittinghoff E, Creasman JM, et al. Weight loss to treat urinary incontinence in overweight and obese women. N Engl J Med. 2009;360(5):481\u201390.","journal-title":"N Engl J Med"},{"issue":"2","key":"847_CR39","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.soard.2016.08.019","volume":"13","author":"K Ait Said","year":"2017","unstructured":"Ait Said K, Leroux Y, Menahem B, Doerfler A, Alves A, Tillou X. Effect of bariatric surgery on urinary and fecal incontinence: prospective analysis with 1-year follow-up. Surg Obes Relat Dis. 2017;13(2):305\u201312.","journal-title":"Surg Obes Relat Dis"},{"issue":"6","key":"847_CR40","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.eururo.2013.02.025","volume":"64","author":"A Bill-Axelson","year":"2013","unstructured":"Bill-Axelson A, Garmo H, Holmberg L, Johansson JE, Adami HO, Steineck G, et al. Long-term distress after radical prostatectomy versus watchful waiting in prostate cancer: a longitudinal study from the Scandinavian Prostate Cancer Group-4 randomized clinical trial. Eur Urol. 2013;64(6):920\u20138.","journal-title":"Eur Urol"},{"issue":"2","key":"847_CR41","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jpsychores.2014.11.019","volume":"78","author":"D Vrijens","year":"2015","unstructured":"Vrijens D, Drossaerts J, van Koeveringe G, Van Kerrebroeck P, van Os J, Leue C. Affective symptoms and the overactive bladder - a systematic review. J Psychosom Res. 2015;78(2):95\u2013108.","journal-title":"J Psychosom Res"},{"issue":"1","key":"847_CR42","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1080\/21681805.2017.1354067","volume":"52","author":"M Ervandian","year":"2018","unstructured":"Ervandian M, Djurhuus JC, H\u00f8yer M, Graugaard-Jensen C, Borre M. Long-term urodynamic findings following radical prostatectomy and salvage radiotherapy. Scand J Urol. 2018;52(1):20\u20136.","journal-title":"Scand J Urol"},{"issue":"6 Suppl","key":"847_CR43","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1016\/j.juro.2012.09.079","volume":"188","author":"EA Gormley","year":"2012","unstructured":"Gormley EA, Lightner DJ, Burgio KL, Chai TC, Clemens JQ, Culkin DJ, et al. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA\/SUFU guideline. J Urol. 2012;188(6 Suppl):2455\u201363.","journal-title":"J Urol"},{"issue":"3","key":"847_CR44","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11934-018-0770-7","volume":"19","author":"M Arcila-Ruiz","year":"2018","unstructured":"Arcila-Ruiz M, Brucker BM. The role of urodynamics in post-prostatectomy incontinence. Curr Urol Rep. 2018;19(3):21.","journal-title":"Curr Urol Rep"},{"issue":"1","key":"847_CR45","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/bju.13246","volume":"117","author":"V Tse","year":"2016","unstructured":"Tse V, King J, Dowling C, English S, Gray K, Millard R, et al. Conjoint Urological Society of Australia and New Zealand (USANZ) and Urogynaecological Society of Australasia (UGSA) Guidelines on the management of adult non-neurogenic overactive bladder. BJU Int. 2016;117(1):34\u201347.","journal-title":"BJU Int"},{"issue":"7","key":"847_CR46","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1111\/j.1464-410X.2012.10948.x","volume":"110","author":"D Tienforti","year":"2012","unstructured":"\u2022 Tienforti D, Sacco E, Marangi F, et al. Efficacy of an assisted low-intensity programme of perioperative pelvic floor muscle training in improving the recovery of continence after radical prostatectomy: a randomized controlled trial. BJU Int. 2012;110(7):1004\u201310 Randomized controlled trial evidencing significant reduction of OAB symptoms at 3 and 6\u00a0months with a structured program of pelvic floor muscle training + biofeedback.","journal-title":"BJU Int"},{"issue":"6","key":"847_CR47","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1016\/j.juro.2011.02.021","volume":"185","author":"HH Lai","year":"2011","unstructured":"\u2022 Lai HH, Boone TB. Implantation of artificial urinary sphincter in patients with post-prostatectomy incontinence, and preoperative overactive bladder and mixed symptoms. J Urol. 2011;185(6):2254\u20139 Retrospective series reporting complete resolution of OAB symptoms in 29% of patients with mixed urinary incontinence after radical prostatectomy.","journal-title":"J Urol"},{"issue":"1","key":"847_CR48","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/nau.22668","volume":"35","author":"R Yiou","year":"2016","unstructured":"Yiou R, B\u00fctow Z, Parisot J, Lingombet O, Augustin D, de la Taille A, et al. Update on 2-year outcomes of the TOMS\u2122 transobturator male sling for the treatment of male stress urinary incontinence. Neurourol Urodyn. 2016;35(1):44\u20137.","journal-title":"Neurourol Urodyn"},{"key":"847_CR49","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.urology.2018.02.022","volume":"115","author":"E Sacco","year":"2018","unstructured":"Sacco E, Gandi C, Vaccarella L, Recupero S, Racioppi M, Pinto F, et al. Titanized transobturator sling placement for male stress urinary incontinence using an inside-out single-incision technique: minimum 12-months follow-up study. Urology. 2018;115:144\u201350.","journal-title":"Urology"},{"issue":"9","key":"847_CR50","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1007\/s00345-014-1447-6","volume":"33","author":"R Yiou","year":"2015","unstructured":"Yiou R, Butow Z, Baron T, Salomon L, Audureau E. Adjustable continence therapy (ProACT\u2122) after male sling failure for patients with post-radical prostatectomy urinary incontinence: a prospective study with one-year follow-up. World J Urol. 2015;33(9):1331\u20136.","journal-title":"World J Urol"},{"issue":"6","key":"847_CR51","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1097\/MOU.0000000000000116","volume":"24","author":"A Cox","year":"2014","unstructured":"Cox A, Herschorn S. Management of the incontinent patient with a sphincteric stricture following radical prostatectomy. Curr Opin Urol. 2014;24(6):578\u201385.","journal-title":"Curr Opin Urol"},{"key":"847_CR52","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.urology.2017.09.025","volume":"113","author":"KD Radadia","year":"2018","unstructured":"Radadia KD, Farber NJ, Shinder B, Polotti CF, Milas LJ, Tunuguntla HSGR. Management of postradical prostatectomy urinary incontinence: a review. Urology. 2018;113:13\u20139.","journal-title":"Urology"},{"issue":"1","key":"847_CR53","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.eururo.2010.10.031","volume":"59","author":"JN Cornu","year":"2011","unstructured":"\u2022 Cornu JN, Merlet B, Ciofu C, et al. Duloxetine for mild to moderate postprostatectomy incontinence: preliminary results of a randomised, placebo-controlled trial. Eur Urol. 2011;59(1):148\u201354 Placebo controlled randomized trial demonstrating efficacy of duloxetine in post-prostatectomy stress urinary incontinence but with no assessment of OAB symptoms.","journal-title":"Eur Urol"},{"issue":"6","key":"847_CR54","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1016\/j.eururo.2006.08.005","volume":"51","author":"MT Filocamo","year":"2007","unstructured":"Filocamo MT, Li Marzi V, Del Popolo G, et al. Pharmacologic treatment in postprostatectomy stress urinary incontinence. Eur Urol. 2007;51(6):1559\u201364.","journal-title":"Eur Urol"},{"issue":"2","key":"847_CR55","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.1464-410X.2007.06980.x","volume":"100","author":"WD Steers","year":"2007","unstructured":"Steers WD, Herschorn S, Kreder KJ, Moore K, Strohbehn K, Yalcin I, et al. Duloxetine compared with placebo for treating women with symptoms of overactive bladder. BJU Int. 2007;100(2):337\u201345.","journal-title":"BJU Int"},{"key":"847_CR56","unstructured":"Burkhard F, Bosch J, Cruz F, et al. EAU guidelines on urinary incontinence 2018. Available at: http:\/\/uroweb.org\/wp-content\/uploads\/EAU-Guidelines-on-Urinary-Incontinence-2018-large-text.pdf ."},{"key":"847_CR57","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.urology.2016.04.003","volume":"93","author":"EC Osterberg","year":"2016","unstructured":"Osterberg EC, Schulster M, Blaivas JG, Maganty A, Lee DJ, Purohit RS. Urethroplasty improves overactive bladder symptoms in men with anterior urethral strictures. Urology. 2016;93:208\u201312.","journal-title":"Urology"},{"issue":"6","key":"847_CR58","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/j.juro.2016.08.015","volume":"196","author":"LA Hampson","year":"2016","unstructured":"Hampson LA, Elliott SP, Erickson BA, Vanni AJ, Myers JB, McClung C, et al. Multicenter analysis of urinary urgency and urge incontinence in patients with anterior urethral stricture disease before and after urethroplasty. J Urol. 2016;196(6):1700\u20135.","journal-title":"J Urol"},{"issue":"Suppl 2","key":"847_CR59","doi-asserted-by":"publisher","first-page":"S186","DOI":"10.21037\/tau.2017.04.07","volume":"6","author":"J Gani","year":"2017","unstructured":"Gani J, Hennessey D. The underactive bladder: diagnosis and surgical treatment options. Transl Androl Urol. 2017;6(Suppl 2):S186\u201395.","journal-title":"Transl Androl Urol"},{"issue":"6","key":"847_CR60","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1097\/MOU.0000000000000115","volume":"24","author":"DK Newman","year":"2014","unstructured":"Newman DK, Guzzo T, Lee D, Jayadevappa R. An evidence-based strategy for the conservative management of the male patient with incontinence. Curr Opin Urol. 2014;24(6):553\u20139.","journal-title":"Curr Opin Urol"},{"issue":"3","key":"847_CR61","first-page":"2684","volume":"13","author":"SW Yang","year":"2016","unstructured":"Yang SW, Na YG, Song KH, Shin JH, Chang YS, Park JM, et al. Lower urinary tract symptoms and efficacy of anticholinergic drugs in patients remaining disease-free after radical retropubic prostatectomy. Urol J. 2016;13(3):2684\u20139.","journal-title":"Urol J"},{"issue":"10","key":"847_CR62","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1089\/end.2014.0342","volume":"28","author":"MA Liss","year":"2014","unstructured":"Liss MA, Morales B, Skarecky D, Ahlering TE. Phase 1 clinical trial of Vesicare\u2122 (solifenacin) in the treatment of urinary incontinence after radical prostatectomy. J Endourol. 2014;28(10):1241\u20135.","journal-title":"J Endourol"},{"issue":"2","key":"847_CR63","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s11255-005-4031-6","volume":"38","author":"D Mitropoulos","year":"2006","unstructured":"Mitropoulos D, Papadoukakis S, Zervas A, Alamanis C, Giannopoulos A. Efficacy of tolterodine in preventing urge incontinence immediately after prostatectomy. Int Urol Nephrol. 2006;38(2):263\u20138.","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"847_CR64","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1080\/21681805.2016.1250810","volume":"51","author":"M Honda","year":"2017","unstructured":"Honda M, Kawamoto B, Morizane S, Hikita K, Muraoka K, Sejima T, et al. Impact of postoperative phosphodiesterase type 5 inhibitor treatment on lower urinary tract symptoms after robot-assisted radical prostatectomy: a longitudinal study. Scand J Urol. 2017;51(1):33\u20137.","journal-title":"Scand J Urol"},{"key":"847_CR65","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/bju.13110","volume":"116 Suppl 3","author":"D Habashy","year":"2015","unstructured":"\u2022 Habashy D, Losco G, Tse V, Collins R, Chan L. Botulinum toxin (OnabotulinumtoxinA) in the male non-neurogenic overactive bladder: clinical and quality of life outcomes. BJU Int. 2015;116 Suppl 3:61\u20135 Only published series assessing a third-line OAB therapy in the post-prostatectomy setting and showing 45% of urgency incontinence resolution after onabotulinum toxin A intradetrusor injections.","journal-title":"BJU Int"},{"issue":"5","key":"847_CR66","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.urology.2015.01.022","volume":"85","author":"M Shim","year":"2015","unstructured":"Shim M, Kim J, Park S, Choi SK, Lee SM, Huh KO, et al. The therapeutic effect of solifenacin succinate on the recovery from voiding dysfunction after radicalprostatectomy in men with clinically localized prostate cancer: a prospective, randomized, controlled study. Urology. 2015;85(5):1123\u20139.","journal-title":"Urology"},{"issue":"4","key":"847_CR67","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.juro.2014.09.106","volume":"193","author":"FJ Bianco","year":"2015","unstructured":"\u2022 Bianco FJ, Albala DM, Belkoff LH, et al. A randomized, double-blind, solifenacin succinate versus placebo control, phase 4, multicenter study evaluating urinary continence after robotic assisted radical prostatectomy. J Urol. 2015;193(4):1305\u201310 Large phase 4 randomized placebo controlled trial showing earlier return to continence after radical prostatectomy with solifenacin 5\u00a0mg.","journal-title":"J Urol"},{"issue":"8","key":"847_CR68","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1111\/ijcp.12433","volume":"68","author":"VW Nitti","year":"2014","unstructured":"Nitti VW, Chapple CR, Walters C, Blauwet MB, Herschorn S, Milsom I, et al. Safety and tolerability of the \u03b23 -adrenoceptor agonist mirabegron, for the treatment of overactive bladder: results of a prospective pooled analysis of three 12-week randomised phase III trials and of a 1-year randomised phase III trial. Int J Clin Pract. 2014;68(8):972\u201385.","journal-title":"Int J Clin Pract"},{"issue":"5","key":"847_CR69","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1517\/14740338.2016.1160055","volume":"15","author":"MC Michel","year":"2016","unstructured":"Michel MC, Gravas S. Safety and tolerability of \u03b23-adrenoceptor agonists in the treatment of overactive bladder syndrome - insight from transcriptosome and experimental studies. Expert Opin Drug Saf. 2016;15(5):647\u201357.","journal-title":"Expert Opin Drug Saf"},{"key":"847_CR70","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.urology.2016.11.008","volume":"100","author":"H Chen","year":"2017","unstructured":"Chen H, Wang F, Yu Z, et al. Efficacy of daily low-dose tadalafil for treating overactive bladder: results of a randomized, double-blind, placebo-controlled trial. Urology. 2017;100:59\u201364.","journal-title":"Urology"},{"issue":"Suppl 3","key":"847_CR71","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1002\/nau.22630","volume":"33","author":"F Cruz","year":"2014","unstructured":"Cruz F, Nitti V. Chapter 5: Clinical data in neurogenic detrusor overactivity (NDO) and overactive bladder (OAB). Neurourol Urodyn. 2014;33(Suppl 3):S26\u201331.","journal-title":"Neurourol Urodyn"},{"issue":"4","key":"847_CR72","doi-asserted-by":"publisher","first-page":"e749","DOI":"10.1016\/j.juro.2017.02.1738","volume":"197","author":"D Hoffman","year":"2016","unstructured":"Hoffman D, Enemchukwu E, Nitti VW. Predictors of urinary retention in male patients receiving intradetrusor botulinum toxin injections. J Urol. 2016;197(4):e749.","journal-title":"J Urol"},{"issue":"8","key":"847_CR73","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1002\/nau.23255","volume":"36","author":"DB Hennessey","year":"2017","unstructured":"Hennessey DB, Hoag N, Gani J. Sacral neuromodulation for detrusor hyperactivity with impaired contractility. Neurourol Urodyn. 2017;36(8):2117\u201322.","journal-title":"Neurourol Urodyn"}],"container-title":["Current Urology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11934-018-0847-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-018-0847-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-018-0847-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T18:30:19Z","timestamp":1662229819000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11934-018-0847-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,10]]},"references-count":73,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["847"],"URL":"https:\/\/doi.org\/10.1007\/s11934-018-0847-3","relation":{},"ISSN":["1527-2737","1534-6285"],"issn-type":[{"value":"1527-2737","type":"print"},{"value":"1534-6285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,10]]},"assertion":[{"value":"10 October 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Benoit Peyronnet is a consultant for Allergan, Medtronic, Astellas and Boston Scientific, and an investigator for Ipsen.Benjamin Brucker is a consultant for Allergan, Watkins Conti, Avadel, Serenity, and an investigator for Ipsen and Medtronic.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"95"}}